Wednesday, July 30, 2025 7/30/2025

Label-free fluorescence lifetime imaging for intraoperative real-time guidance of neurological procedures

Award Number: R01CA250512
ORGANIZATION: NATIONAL CANCER INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 12/15/2020
PERIOD OF PERFORMANCE END DATE: 11/30/2026

Group Awards By:

View Award Description

Label-free fluorescence lifetime imaging for intraoperative real-time guidance of neurological procedures - PROJECT SUMMARY/ABSTRACT The outcome of brain tumor surgery is critically dependent on the neurosurgeon's ability to distinguish between abnormal and normal tissue in real-time. Our goal is to enhance this discrimination by using label-free Fluorescence Lifetime Imaging (FLIm) to detect tissue biochemical and metabolic characteristics that distinguish among different tissue types and, by integrating FLIm into the neurosurgical workflow, to provide this information in a real-time, visual format useful for guiding tumor biopsy and resection. FLIm-derived tissue fluorescence feature information will be co-registered with the preoperative-MRI (pMRI) and projected onto the conventional surgical microscope field-of-view (FOV). This should improve delineation of tumor margins and thus increase both the diagnostic yield of brain biopsy and the extent of tumor resection. The proposed FLIm technique will incorporate the following features: (1) Safe, rapid, and simultaneous measurement of time-resolved fluorescence decays in multiple spectral emission bands that will acquire extensive information in one scanning measurement of a large area of tissue selected by the surgeon; and (2) Fast analysis, display, and augmentation of fluorescence parameters that enable real-time visualization of optical data encoding diagnostic information onto the surgical FOV. The proposed clinical studies using FLIm as a stand- alone tool will establish classifiers to correlate FLIm parameters with specific tissue pathologies, an important step in demonstrating FLIm's diagnostic value. The proposed integration of FLIm as an adjunct to the neuronavigation system and surgical microscope will provide data for combined analysis to validate the benefit of FLIm diagnostics in neurosurgical procedures. Three aims are proposed: Aim 1) Construct and integrate a FLIm device as a diagnostic adjunct with conventional neurosurgical tools. Aim 2) Clinically evaluate the relationship between FLIm parameters and distinct tissue pathologies and develop classifiers for different tissue types. Aim 3) Validate FLIm for real-time intraoperative guidance through a prospective analysis. In summary, this study will demonstrate the clinical feasibility and utility of FLIm for intraoperative real-time assessment of neurosurgical margins and the resulting improvement in neuropathologic diagnostic yield. The acquired FLIm parameter database will enable subsequent clinical trials for automated tissue classification and diagnostic prediction. The new FLIm instrumentation, characterized by simple, fast and flexible data acquisition and display, and its seamless integration with existing neurosurgical imaging, will provide a less expensive alternative to intraoperative MRI and a valuable complement to current standard-of-care diagnostic procedures. Success in this area will warrant a more generalized use of FLIm in surgical oncology (other cancers) as well as guided interventions for treatment of functional neurologic diseases (e.g. epilepsy, neurodegenerative diseases).


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $550,630 )
2025	2025	UNIVERSITY OF CALIFORNIA, DAVIS	1850 RESEARCH PARK DR STE 300	DAVIS	CA	95618	YOLO	USA	Cancer Detection and Diagnosis Research	001	5	7/3/2025	NON-COMPETING CONTINUATION	$55,063
2025	2025	UNIVERSITY OF CALIFORNIA, DAVIS	1850 RESEARCH PARK DR STE 300	DAVIS	CA	95618	YOLO	USA	Cancer Detection and Diagnosis Research	000	5	11/25/2024	NON-COMPETING CONTINUATION	$495,567
														Subtotal = $550,630

Issue Date FY: 2024 ( Subtotal = $105,412 )
2024	2024	UNIVERSITY OF CALIFORNIA, DAVIS	1850 RESEARCH PARK DR, STE 300	DAVIS	CA	95618	YOLO	USA	Cancer Detection and Diagnosis Research	000	4	12/1/2023	NON-COMPETING CONTINUATION	$74,218
2024	2024	UNIVERSITY OF CALIFORNIA, DAVIS	1850 RESEARCH PARK DR STE 300	DAVIS	CA	95618	YOLO	USA	Cancer Detection and Diagnosis Research	001	4	4/23/2024	NON-COMPETING CONTINUATION	$31,194
														Subtotal = $105,412

Issue Date FY: 2023 ( Subtotal = $544,714 )
2023	2023	UNIVERSITY OF CALIFORNIA, DAVIS	1850 RESEARCH PARK DR, STE 300	DAVIS	CA	95618	YOLO	USA	Cancer Detection and Diagnosis Research	000	3	11/22/2022	NON-COMPETING CONTINUATION	$500,247
2023	2023	UNIVERSITY OF CALIFORNIA, DAVIS	1850 RESEARCH PARK DR, STE 300	DAVIS	CA	95618	YOLO	USA	Cancer Detection and Diagnosis Research	001	3	3/15/2023	NON-COMPETING CONTINUATION	$44,467
														Subtotal = $544,714

Issue Date FY: 2022 ( Subtotal = $620,425 )
2022	2022	UNIVERSITY OF CALIFORNIA, DAVIS	1850 RESEARCH PARK DR, STE 300	DAVIS	CA	95618	YOLO	USA	Cancer Detection and Diagnosis Research	001	2	4/28/2022	NON-COMPETING CONTINUATION	$50,648
2022	2022	UNIVERSITY OF CALIFORNIA, DAVIS	1850 RESEARCH PARK DR, STE 300	DAVIS	CA	95618	YOLO	USA	Cancer Detection and Diagnosis Research	000	2	11/18/2021	NON-COMPETING CONTINUATION	$569,777
														Subtotal = $620,425

Issue Date FY: 2021 ( Subtotal = $613,418 )
2021	2021	UNIVERSITY OF CALIFORNIA, DAVIS	1850 RESEARCH PARK DR, STE 300	DAVIS	CA	95618	YOLO	USA	Cancer Detection and Diagnosis Research	000	1	12/4/2020	NEW	$613,418
														Subtotal = $613,418

Grand Total All Awards = $2,434,599

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Label-free fluorescence lifetime imaging for intraoperative real-time guidance of neurological procedures

Award Number: R01CA250512

ORGANIZATION: NATIONAL CANCER INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 12/15/2020

PERIOD OF PERFORMANCE END DATE: 11/30/2026

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer